Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project (EPIC-BS)

Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project (EPIC-Baseline-Survey)

The subject of the study is an online survey of doctors and nurses who provide (intensive) medical care to patients.

Study Overview

• Status: Withdrawn
• Conditions: Palliative Medicine

Detailed Description

Charité will support this international survey as part of the preparatory phase of the "Europe-wide harmonized and recommended palliative care practice for ICU" approved HORIZON grant application EPIC (EA2/291/23), to which this ethics application refers.

Participants will be contacted via the mailing list of ESAIC (European Organization for Anaesthesia, Intensive Care, Pain and Perioperative Medicine), ESICM (European Society of Intensive Care Medicine), DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine (DIVI) and the European Association for Palliative Care (EAPC).

• Study Type: Observational

Contacts and Locations

Study Locations

• Germany
  • Berlin, Germany, 13353
    • Recruiting
    • Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin
    • Principal Investigator: Claudia Spies, MD
    • Sub-Investigator: Andreas Edel, MD
    • Contact: Claudia Spies, MD Prof.; Phone Number: +49 30 531 012; Email: claudia.spies@charite.de
    • Principal Investigator: Sascha Tafelski, MD
    • Sub-Investigator: Susanne Jöbges, MD
    • Sub-Investigator: Christiane Hartog, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

• Sampling Method: Probability Sample

Study Population

Doctors or nursing staff involved in the intensive medical care of patients which can be contacted by a list of a specialist association

Description

Inclusion Criteria:

• All doctors or nursing staff involved in the intensive medical care of patients and consent to the survey via the distribution list of a specialist association

Exclusion Criteria:

• Incomplete data

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Barriers 1	Barriers in palliative care regarding implementation of therapeutic goals (implementation rate symptom assessment for e.g. breathing and dyspnea).	01.04.2024 - 30.06.2024
Barriers 2	Barriers in palliative care regarding implementation of patient automomy (implementation rate to define advance directives and power of attorney).	01.04.2024 - 30.06.2024

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Measures 1	Measures to be taken in the palliative medical treatment situation (implementation rate to define and document end-of-life-decisions).	01.04.2024 - 30.06.2024
Measures 2	Evaluation of measures to be taken in the palliative medical treatment situation (family involvement in end-of-life-decisions).	01.04.2024 - 30.06.2024
Resources 1	Personnel resources in palliative care (rate of specialized palliative care team available in ICUs).	01.04.2024 - 30.06.2024
Resources 2	Other resources in palliative care (rate availability of psychological support)	01.04.2024 - 30.06.2024

Collaborators and Investigators

• Sponsor: Charite University, Berlin, Germany
• Collaborators: King's College Hospital NHS Trust; National and Kapodistrian University of Athens; European Commission
• Investigators: Study Chair: Claudia Spies, MD, Prof., Charite University, Berlin, Germany

Study record dates

Study Major Dates

• Study Start (Estimated): April 1, 2024
• Primary Completion (Estimated): June 30, 2024
• Study Completion (Estimated): June 30, 2024

Study Registration Dates

• First Submitted: February 22, 2024
• First Submitted That Met QC Criteria: March 12, 2024
• First Posted (Actual): March 15, 2024

Study Record Updates

• Last Update Posted (Actual): March 18, 2024
• Last Update Submitted That Met QC Criteria: March 15, 2024
• Last Verified: March 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: EPIC-Baseline-Survey

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No